Table 1.
Schedule of events following SPIRIT guidelines
| Enrollment/baseline visit (within 30 d of procedure) | Procedure | Post–index procedure |
||||||
|---|---|---|---|---|---|---|---|---|
| Predischarge | Therapy consolidation period |
12 mo | 24 mo | |||||
| 1 mo | 3 mo | 6 mo | ||||||
| Enrollment | X | |||||||
| Eligibility screen | X | |||||||
| Informed consent | X | |||||||
| Assessments | ||||||||
| Medication review | X | X | X | X | X | X | ||
| Symptom review | X | X | X | X | X | X | ||
| 12-lead ECG | X | X | X | X | X | X | X | |
| 7-day heart rate monitoring | X | X | X | X | ||||
| AEs (MAEs, AEs) | X | X | X | X | X | X | X | |
| Exercise regimen∗ | X | X | X | X | X | X | ||
| TTE | X† | X | ||||||
| 6-min walk test | X | X | X | X | ||||
| SAS assessment | X | X | X | X | ||||
| SF-12 | X | X | X | X | ||||
Unscheduled visits will include review of symptoms and medications, 12-lead ECG, MAE/AE assessment, and computed tomography/magnetic resonance imaging if clinical evidence of constrictive pericarditis and/or superior vena cava/inferior vena cava stenosis.
AE = adverse event; ECG = electrocardiogram, MAE = major adverse event; SAS = Self-Rating Anxiety Scale; SF-12 = 12-item Short Form Survey; SPIRIT = Standard Protocol Items: Recommendations for Interventional Trials; TTE = transthoracic echocardiogram.
At physician’s discretion or standard of care.
If symptoms suggestive of delayed pericardial effusion or pericarditis are reported (eg, chest pain, shortness of breath).